ArticleJournal of clinical laboratory analysis2022

PBMC CDC42 reveals the disease activity and treatment efficacy of TNF inhibitor in patients with ankylosing spondylitis.

Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.